To Study the Effect of Shreerasadi Churna in Decreasing Diarrhea in Childrean Age Group 1 to 12 Year.
Phase 2/3
Recruiting
- Conditions
- Disease of digestive system, unspecified. Ayurveda Condition: ATISARAH,
- Registration Number
- CTRI/2025/05/086251
- Lead Sponsor
- Dr Omkar Sampat Madake
- Brief Summary
This is a single arm clinical study in which the medicine "Shreerasadi Churna” will be provided to 32 patients showing sign and symptoms of Atisara (Diarrhea). The age group taken for the study trial will be in between 1 years to 12 years. Shreerasadi Churna with Madhu will be given on 0 th day Thrice a Day for 5 days. Dose will be calculated by age formula. Follow up will be done on 2nd and 5th day and the total duration of case study will be 5 days. The final conclusion will be drawn on the basis of statistical methods.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- All
- Target Recruitment
- 32
Inclusion Criteria
- Patient with 1 year to 12 year age group will be selected irrespective of sex, religion & socio economic class.
- Patient of acute diarrhea with no signs of dehydration(according to WHO).
- Atisara less than 5 days (less than 6 episodes/day).
- ORS will given to the patient.
- Patient having classical signs & symptoms of Atisara (Diarrhea).
Exclusion Criteria
- Patient suffering from persistent diarrhea, chronic diarrhea, pravahika ,persistent vomitting.
- Diarrhea due to any immune deficiency like acquired or congenital.
- Patients of some dehydration to severe dehydration (according to WHO) 4.
- Patients suffering from any chronic or systemic illness.
- Atisara due to any food poisoning or iatrogenic origin.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method We will see the effect of interventional drug on the signs & symptoms of Atisara are expected to be reduced after the use of Shreerasadi Churna in childrens. 5 days study with follow up on 2nd and 5th day | (0,2,5 days)
- Secondary Outcome Measures
Name Time Method We will see reoccurrence and any side effect of interventional drug.
Trial Locations
- Locations (1)
Dr. D. Y. Patil College of Ayurved and Research Centre
🇮🇳Pune, MAHARASHTRA, India
Dr. D. Y. Patil College of Ayurved and Research Centre🇮🇳Pune, MAHARASHTRA, IndiaDr Omkar Sampat MadakePrincipal investigator9623904244omkarmadke999@gmail.com